5-157460209-C-T
Position:
Variant summary
Our verdict is Benign. Variant got -10 ACMG points: 0P and 10B. BP4_StrongBP6_ModerateBS2
The ENST00000517951.5(ADAM19):c.*1741+28056G>A variant causes a intron, NMD transcript change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000615 in 1,485,562 control chromosomes in the GnomAD database, including 7 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★).
Frequency
Genomes: 𝑓 0.0033 ( 5 hom., cov: 33)
Exomes 𝑓: 0.00031 ( 2 hom. )
Consequence
ADAM19
ENST00000517951.5 intron, NMD_transcript
ENST00000517951.5 intron, NMD_transcript
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.0450
Genes affected
ADAM19 (HGNC:197): (ADAM metallopeptidase domain 19) This gene encodes a member of the ADAM (a disintegrin and metalloprotease domain) family. Members of this family are membrane-anchored proteins structurally related to snake venom disintegrins and have been implicated in a variety of biological processes involving cell-cell and cell-matrix interactions, including fertilization, muscle development, and neurogenesis. This member is a type I transmembrane protein and serves as a marker for dendritic cell differentiation. It has been demonstrated to be an active metalloproteinase, which may be involved in normal physiological processes such as cell migration, cell adhesion, cell-cell and cell-matrix interactions, and signal transduction. It is proposed to play a role in pathological processes, such as cancer, inflammatory diseases, renal diseases, and Alzheimer's disease. [provided by RefSeq, May 2013]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -10 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.53).
BP6
Variant 5-157460209-C-T is Benign according to our data. Variant chr5-157460209-C-T is described in ClinVar as [Benign]. Clinvar id is 2763581.Status of the report is criteria_provided_single_submitter, 1 stars.
BS2
High Homozygotes in GnomAd4 at 5 AR gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
NIPAL4 | NM_001099287.2 | upstream_gene_variant | ENST00000311946.8 | NP_001092757.2 | ||||
NIPAL4 | NM_001172292.2 | upstream_gene_variant | NP_001165763.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
NIPAL4 | ENST00000311946.8 | upstream_gene_variant | 1 | NM_001099287.2 | ENSP00000311687 | P1 |
Frequencies
GnomAD3 genomes AF: 0.00331 AC: 504AN: 152192Hom.: 5 Cov.: 33
GnomAD3 genomes
AF:
AC:
504
AN:
152192
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000719 AC: 65AN: 90410Hom.: 0 AF XY: 0.000633 AC XY: 31AN XY: 48966
GnomAD3 exomes
AF:
AC:
65
AN:
90410
Hom.:
AF XY:
AC XY:
31
AN XY:
48966
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000308 AC: 410AN: 1333254Hom.: 2 Cov.: 32 AF XY: 0.000288 AC XY: 188AN XY: 653184
GnomAD4 exome
AF:
AC:
410
AN:
1333254
Hom.:
Cov.:
32
AF XY:
AC XY:
188
AN XY:
653184
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00331 AC: 504AN: 152308Hom.: 5 Cov.: 33 AF XY: 0.00285 AC XY: 212AN XY: 74484
GnomAD4 genome
AF:
AC:
504
AN:
152308
Hom.:
Cov.:
33
AF XY:
AC XY:
212
AN XY:
74484
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
2
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not provided Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | May 23, 2023 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at